Concerto Versa™ Detachable Coils
DeviceConcerto Versa™ detachable coil is indicated for arterial and venous embolization in the peripheral vasculature
NCT Number: NCT07639853
The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.
Trial opening soon.
Get Notified22 year and older
All sexes
Observational
The Concerto Versa™ Health Care Professional (HCP) Clinical Assessment is a multicenter, prospective per patient HCP recollection survey. Participating HCPs will document their individual use case experience following routine utilization of Concerto Versa™ in accordance with the approved device labeling. Individual use cases will be entered within 72 hours of device usage to identify periprocedural safety incidents and evaluate device performance. At least 30 use cases will be collected and aggregated from participating HCPs. This data collection is a for a single point in time, with no patient follow-up. Individual HCP responses for each case will be aggregated by a third party vendor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Concerto Versa™ detachable coil is indicated for arterial and venous embolization in the peripheral vasculature
Time frame: During the Index Procedure
The rate of peri-procedural adverse events related to device and/or procedure.
Time frame: During the Index Procedure
Technical success is defined as successful delivery and detachment of the coil, and removal of the delivery-pusher.
Time frame: During the Index Procedure
Peri-procedural success is defined as ability of the device to successfully obstruct or reduce the rate of blood flow to the target lesion as determined by physician judgment.
Contact information is provided by the study sponsor or research team.
Elizabeth Hunt
CONTACT
Samantha Udondem
CONTACT
Medtronic Endovascular
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07118631
Arteriovenous Malformation, Arteriovenous Malformations
Beijing, China
View Trial DetailsNCT03269734
Aneurysm, Aortic Aneurysm
Paris, France
View Trial DetailsNCT00389935
Angiodysplasia, Arteriovenous Malformation
Augusta, Georgia, United States
View Trial DetailsNCT07156409
Arteriovenous Fistula, Arteriovenous Malformation
View Trial Details